Development of Dermatitis Herpetiformis in Chronic Plaque Psoriasis

by Ruby Lee, Yolanka Lobo, Lynda Spelman
Published 2021-02-01

Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature

by Yolanka Lobo, Ruby C. Lee, Lynda Spelman
Published 2021-05-01

Toxoplasmosis in a patient receiving ixekizumab for psoriasis

by Yolanka Lobo, BPhysio, MBBS, Teagan Holland, RN, Lynda Spelman, MBBS, FACD
Published 2020-03-01

Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study.

by Miriam Calao, Jodie L Wilson, Lynda Spelman, Laurent Billot, Diana Rubel, Alan D Watts, Gregor B E Jemec
Published 2018-01-01

Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial

by Lyn Guenther, Alison Potts Bleakman, Jamie Weisman, Yves Poulin, Lynda Spelman, Russel Burge, Janelle Erickson, Kristin Todd, Clinton C. Bertram, Caitriona Ryan
Published 2020-01-01

A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients

by Miko Yamada, Dennis M. Miller, Melinda Lowe, Casey Rowe, Dominic Wood, H. Peter Soyer, Kelly Byrnes-Blake, Julia Parrish-Novak, Laura Ishak, James M. Olson, Gordon Brandt, Paul Griffin, Lynda Spelman, Tarl W. Prow
Published 2021-09-01